Loading...
•
Mar 31, 2021
Atricure Q1 2021 Earnings Report
AtriCure's first quarter 2021 financial results were announced, demonstrating revenue growth despite COVID-19 headwinds.
Key Takeaways
AtriCure reported a revenue of $59.3 million for Q1 2021, representing an 11.4% increase compared to Q1 2020. The U.S. revenue increased by 15.7%, while international revenue decreased by 8.1%. The company's net loss per share was $0.38, and the adjusted loss per share was $0.32.
Revenue for Q1 2021 was $59.3 million, up 11.4% year-over-year.
U.S. revenue increased by 15.7% driven by increased sales across key products.
International revenue decreased by 8.1% due to COVID-19 restrictions.
Net loss per share was $0.38, and adjusted loss per share was $0.32.
Revenue by Geographic Location
Forward Guidance
Full year 2021 revenue is now projected to be approximately $252 million to $256 million. The Company is maintaining guidance for full year 2021 adjusted EBITDA loss of approximately $10 million and adjusted loss per share of $1.15.
Positive Outlook
- Full year 2021 revenue is projected to be approximately $252 million to $256 million.
- Maintaining guidance for full year 2021 adjusted EBITDA loss of approximately $10 million.
- Maintaining guidance for full year 2021 adjusted loss per share of $1.15.
Challenges Ahead
- Continued uncertainty relating to the dynamic environment with the COVID-19 pandemic could materially impact this projection.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...